Imagen de Portada

Changes in the quality of life of adults with sickle cell disease following allogeneic stem cell transplantation: A mixed‐methods, prospective cohort study

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Elisabeth Dovern, Sterre J. A. M. Nijland, Annemarie M. J. Braamse, Maud M. van Muilekom, Elisabeth M. J. Suijk, Gerianne M. Hoogendoorn, Charlotte F. J. van Tuijn, Michael R. DeBaun, Bart J. Biemond, Lotte Haverman, Erfan Nur
Formato:	Artículo Open Access
Publicado:	Wiley 2025
Materias:	HemaSphere
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Cerebral hemodynamics and oxygen metabolism in patients with milder and severe forms of sickle cell disease and thalassemia
por: Liza Afzali‐Hashemi, et al.
Publicado: (2024)

Who owns that blood? Recontacting donors with results from genetic testing after allogeneic hematopoietic cell transplantation
por: Mirjam E. Belderbos, et al.
Publicado: (2025)

Time‐restricted versus standard‐duration immunosuppression after allogeneic hematopoietic stem cell transplantation: Results of the prospective randomized HOVON‐96 trial
por: Annoek E. C. Broers, et al.
Publicado: (2024)

Can health inequalities in sickle cell disease be addressed through novel therapies?
por: Stephen P. Hibbs, et al.
Publicado: (2025)

Lower efficacy of transfusion of red blood cells from donors with sickle cell trait
por: Monika Dzieciatkowska, et al.
Publicado: (2026)

Examining the secret life of the spleen in sickle cell disease
por: Adama Ladu, et al.
Publicado: (2025)

News on sickle cell disease: Heme‐driven disordered erythropoiesis
por: Francesca Vinchi
Publicado: (2024)

Inflammatory pathways and anti‐inflammatory therapies in sickle cell disease
por: Karina Tozatto‐Maio, et al.
Publicado: (2024)

Posttransplantation clonal dynamics of hematopoietic stem cells carrying prenatal and early‐life DNMT3A mutations
por: Lucca L. M. Derks, et al.
Publicado: (2025)

New approaches in gene therapy for sickle cell disease, moving in vivo
por: David G. Kent
Publicado: (2024)

Iron, arginine, and redox metabolism in peripheral blood mononuclear cells distinguishes sickle cell disease and pulmonary hypertension
por: Francesca I. Cendali, et al.
Publicado: (2026)

Know your blood: Addressing barriers to preconceptual screening for sickle cell disease
por: Ernel Boadi, et al.
Publicado: (2025)

Correction to “New approaches in gene therapy for sickle cell disease, moving in vivo”
Publicado: (2024)

Mitochondrial retention in mature red blood cells from patients with sickle cell disease is associated with stress erythropoiesis but not with proinflammatory state
por: Marc Romana, et al.
Publicado: (2024)

Elevated serum heme oxygenase‐1 in pediatric sickle cell disease: Insights from the SickleGenAfrica Network
por: Anna M. Sowa, et al.
Publicado: (2025)

Cellular therapies for sickle cell disease: Should we be calling them a cure?
por: Lydia O. Okoibhole, et al.
Publicado: (2025)

Childhood myelodysplastic syndromes: Is cytoreductive therapy useful before allogeneic hematopoietic stem cell transplantation?
por: Baptiste Le Calvez, et al.
Publicado: (2024)

Azathioprine/hydroxyurea preconditioning prior to nonmyeloablative matched sibling donor hematopoietic stem cell transplantation in adults with sickle cell disease: A prospective observational cohort study
por: Elisabeth Dovern, et al.
Publicado: (2024)

Long‐term outcome of 2‐year survivors after allogeneic hematopoietic cell transplantation for acute leukemia
por: Marion Larue, et al.
Publicado: (2024)

HLA evolutionary divergence score after donor lymphocyte infusion following allogeneic hematopoietic stem cell transplantation
por: Sophie Le Grand, et al.
Publicado: (2025)

MeMAGEN: A Phase IIa/IIb open‐label trial of memantine testing safety and tolerability in sickle cell patients
por: Ariel Koren, et al.
Publicado: (2026)

Prospective phase II study of allogeneic hematopoietic stem cell transplantation with targeted busulfan, fludarabine, and etoposide conditioning in pediatric acute lymphoblastic leukemia
por: Kyung Taek Hong, et al.
Publicado: (2024)

Folate receptor beta targeting of tumor‐associated macrophages improves lymphoma cell responses to CD19 CAR T cells
por: Kerttu Kalander, et al.
Publicado: (2026)

Prognostic significance of immune reconstitution following CD19 CAR T‐cell therapy for relapsed/refractory B‐cell lymphoma
por: Sophia Stock, et al.
Publicado: (2025)

T‐cell lymphoblastic lymphoma in constitutional mismatch repair deficiency (CMMRD): Exploring treatment opportunities
por: Emma Kroeze, et al.
Publicado: (2024)

Fetal‐hemoglobin‐expressing red blood cells (“F cells”) consist of three distinct types as revealed by single‐cell transcriptomic analysis of circulating reticulocytes
por: Helen Rooks, et al.
Publicado: (2025)

Delving deeper into the pathogenesis and genomics of posttransplant diffuse large B‐cell lymphoma
por: Flore Sneyers, et al.
Publicado: (2025)

IDALLO study: A retrospective multicenter study of the SFGM‐TC evaluating the efficacy and safety of ivosidenib in relapsed IDH1‐mutated AML after allogeneic hematopoietic cell transplantation
por: Adrien Caillet, et al.
Publicado: (2024)

TET3 regulates hematopoietic stem cell homeostasis during embryonic and adult hematopoiesis
por: Harmony C. Ketchum, et al.
Publicado: (2025)

Minimal residual disease assessment following CD19‐targeted therapy in B‐cell precursor acute lymphoblastic leukemia using standardized 12‐color flow cytometry: A EuroFlow study
por: Martijn W. C. Verbeek, et al.
Publicado: (2025)

Transcriptional profiling directs the classification of acute leukemias of ambiguous lineage into AML, B‐ALL, or T‐ALL
por: Roger Mulet‐Lazaro, et al.
Publicado: (2025)

Hypomorphic ATP11c is a novel regulator of decreased efficacy of transfused red blood cells in humans and mice
por: James C. Zimring, et al.
Publicado: (2026)

Autologous stem cell transplantation in NK/T‐cell lymphoma: Prognostic impact of EBV‐DNA in a multinational cohort—A study by the EBMT Lymphoma Working Party
por: Philipp Berning, et al.
Publicado: (2025)

High pretreatment disease burden as a risk factor for infectious complications following CD19 chimeric antigen receptor T‐cell therapy for large B‐cell lymphoma
por: Maeve A. O'Reilly, et al.
Publicado: (2024)

Inhibiting the alarmin‐driven hematopoiesis‐stromal cell crosstalk in primary myelofibrosis ameliorates bone marrow fibrosis
por: Hélène F. E. Gleitz, et al.
Publicado: (2025)

Sharper definitions, blurred lines: The clinical aftermath of the revised antiphospholipid syndrome criteria
por: Lauren E. Merz, et al.
Publicado: (2026)

From hypoxia single‐cell gene signatures to HIF targeting of AML leukemic stem cells
por: Thomas Mercher, et al.
Publicado: (2024)

Correction to “Single‐cell RNA sequencing of pediatric Hodgkin lymphoma to study the inhibition of T cell subtypes”
Publicado: (2024)

Tet2 deficiency promotes IgG1+ B‐cell expansion and differentiation blockade through deregulation of the Nfkbia –c‐Rel axis
por: Hussein Ghamlouch, et al.
Publicado: (2026)

Treatment outcomes in patients with large B‐cell lymphoma after progression to chimeric antigen receptor T‐cell therapy
por: Gloria Iacoboni, et al.
Publicado: (2024)